Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Chiarle

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Nature Methods|March 19, 2013
Nucleotide-resolution DNA double-strand break mapping by next-generation sequencingNicola Crosetto, Abhishek Mitra, Maria Joao Silva, et al.
Neoplasia (New York, N.Y.)|May 2, 2013
Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complexRocco Piazza, Vera Magistroni, Angela Mogavero, et al.
The Journal of Clinical Investigation|November 18, 2006
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genesRoberto Piva, Elisa Pellegrino, Michela Mattioli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
An in vivo model of Met-driven lymphoma as a tool to explore the therapeutic potential of Met inhibitorsPaolo Accornero, Giuseppe Lattanzio, Tony Mangano, et al.
Current Issues in Molecular Biology|January 30, 2026
Evaluation of the Role of AID-Induced Mutagenesis in Resistance to B-Cell Receptor Pathway Inhibitors in Chronic Lymphocytic LeukemiaChiara Pighi, Alessandro Gasparetto, Elisa Genuardi, et al.
Oncotarget|April 28, 2016
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1Claudia Voena, Lydia M Varesio, Liye Zhang, et al.
Nature|August 8, 2017
A Braf kinase-inactive mutant induces lung adenocarcinomaPatricia Nieto, Chiara Ambrogio, Laura Esteban-Burgos, et al.
Cancers|October 17, 2020
High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma CellsDomenico Sorrentino, Julie Frentzel, Géraldine Mitou, et al.
Neuron|September 7, 2022
Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapyAhram Jang, Boryana Petrova, Taek-Chin Cheong, et al.
Nature Communications|June 14, 2024
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancersTaek-Chin Cheong, Ahram Jang, Qi Wang, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Nature Methods|March 19, 2013
Nucleotide-resolution DNA double-strand break mapping by next-generation sequencingNicola Crosetto, Abhishek Mitra, Maria Joao Silva, et al.
Neoplasia (New York, N.Y.)|May 2, 2013
Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complexRocco Piazza, Vera Magistroni, Angela Mogavero, et al.
The Journal of Clinical Investigation|November 18, 2006
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genesRoberto Piva, Elisa Pellegrino, Michela Mattioli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
An in vivo model of Met-driven lymphoma as a tool to explore the therapeutic potential of Met inhibitorsPaolo Accornero, Giuseppe Lattanzio, Tony Mangano, et al.
Current Issues in Molecular Biology|January 30, 2026
Evaluation of the Role of AID-Induced Mutagenesis in Resistance to B-Cell Receptor Pathway Inhibitors in Chronic Lymphocytic LeukemiaChiara Pighi, Alessandro Gasparetto, Elisa Genuardi, et al.
Oncotarget|April 28, 2016
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1Claudia Voena, Lydia M Varesio, Liye Zhang, et al.
Nature|August 8, 2017
A Braf kinase-inactive mutant induces lung adenocarcinomaPatricia Nieto, Chiara Ambrogio, Laura Esteban-Burgos, et al.
Cancers|October 17, 2020
High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma CellsDomenico Sorrentino, Julie Frentzel, Géraldine Mitou, et al.
Neuron|September 7, 2022
Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapyAhram Jang, Boryana Petrova, Taek-Chin Cheong, et al.
Nature Communications|June 14, 2024
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancersTaek-Chin Cheong, Ahram Jang, Qi Wang, et al.
Pageof 16